U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298083) titled 'DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins' on Dec. 17.
Brief Summary: The goal of this clinical research study is to learn if a handheld Mass Spectrometry device (MasSpec Pen) can accurately distinguish between masses, neurofibroma, and normal tissue during surgery.
Study Start Date: April 01, 2026
Study Type: OBSERVATIONAL
Condition:
Neurofibromas
MPNST
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Disclaimer: Curated by HT Syndication....